Stephen Brannan
2021
In 2021, Stephen Brannan earned a total compensation of $4.5M as Chief Medical Officer at Karuna Therapeutics, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $279,000 |
|---|---|
| Option Awards | $3,786,098 |
| Salary | $450,000 |
| Other | $8,700 |
| Total | $4,523,798 |
Brannan received $3.8M in option awards, accounting for 84% of the total pay in 2021.
Brannan also received $279K in non-equity incentive plan, $450K in salary and $8.7K in other compensation.
Rankings
In 2021, Stephen Brannan's compensation ranked 2,931st out of 12,406 executives tracked by ExecPay. In other words, Brannan earned more than 76.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,931 out of 12,406 | 76th |
Division Manufacturing | 1,168 out of 5,494 | 79th |
Major group Chemicals And Allied Products | 465 out of 2,369 | 80th |
Industry group Drugs | 408 out of 2,090 | 81st |
Industry Pharmaceutical Preparations | 275 out of 1,537 | 82nd |
Source: SEC filing on April 27, 2022.
Brannan's colleagues
We found four more compensation records of executives who worked with Stephen Brannan at Karuna Therapeutics in 2021.